Lectures

Conaway MR. Statistical Design Considerations for Combination Studies. FDA Workshop on Optimizing Dosages for Oncology Drug Products: Using Modeling and Simulation to Select Dosages for Combination Therapies and New Indications. National Harbor MD, November 2023
Helman JE and Conaway MR. A semi-competing risks framework to incorporate dose reductions into dose-finding. 7th Workshop on Early stage Design, Cambridge University, October 2022
Conaway MR and Petroni GR. Designs for dose-finding trials of agents with non-monotonic dose-efficacy curves. 7^th Workshop on Early stage Design, Cambridge University, October 2022
Conaway MR, Evaluating efficacy in dose-finding studies. Division of Biometrics IX, Center for Drug Evaluation and Research, FDA, Virtual, June 2022
Conaway MR, Designs for dose-finding trials of agents with non-monotonic dose-efficacy curves, University of Illinois-Chicago, Virtual, March 2022
Conaway MR, Designs for dose-finding trials of agents with non-monotonic dose-efficacy curves, Virginia Commonwealth University, Richmond VA, September 2021
Horton BJ, The Impact of Scientific Review on Early-Phase Clinical Trial Design, Joint Statistical Meetings, Virtual, August 2021
Horton BJ, Early phase cancer clinical trial design for dose finding of treatment combinations across patient groups, Joint Statistical Meetings, Virtual, August 2020
Wages NA, Novel designs for contemporary dose-finding studies, American Association for Clinical Research Annual Meeting, Virtual, June 2020
Wages NA, Adaptive dose-finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapy, ENAR Spring Meeting, Virtual, March 2020
Conaway MR, Role of early phase design in the drug development process, New York University, New York NY, September 2019
Horton BJ, Implementation of an Adaptive Early Phase Trial Design for Drug Combinations, Joint Statistical Meetings, Denver CO, August 2019
Wages NA, Flexible designs for contemporary dose-finding problems, Dana-Farber Cancer Institute Department of Data Sciences Seminar Series, Boston MA, February 2019
Wages NA, Shift models for dose-finding in partially ordered groups, 6th Early Phase Adaptive Trials Workshop, Los Angeles CA, November 2018
Horton BJ, Reversals in Early Phase Dose Finding Trials, Joint Statistical Meetings, Vancouver British Columbia Canada, August 2018
Wages NA, Flexible early-phase design for combination therapies, The 2nd Oncostat Annual Symposium, Chicago IL, May 2018
Conaway MR, Clinical Trial Design, Part 2: Dose-Finding, American Association for Clinical Research, Annual Meeting Methods Workshop, Clinical Trial Design, Chicago IL, April 2018
Petroni GR, Successful implementation of novel early phase designs for combination therapies, Part 3: Trials Utilizing Combination Therapies, American Association for Clinical Research, Annual Meeting Methods Workshop, Clinical Trial Design, Chicago IL, April 2018
Wages NA, Designs for phase I oncology trials, Society for Clinical Trials Webinar, Virtual, October 2017
Conaway MR, The role of early stage trial design in the drug development process, Annual Workshop on Early Phase Design, Cedars-Sinai Cancer Center, Los Angeles CA, September 2017
Iasonos A, Wages NA, Impact of model complexity on adaptive dose-finding methods, Webinar for Boeringer-Ingleheim Pharamceuticals, Inc, Virtual, September 2017
Conaway MR, Patient Heterogeneity in Dose-Finding Trials, Part 1: Methods for 2 groups, Henry Stewart Talks, Virtual, August 2017
Conaway MR, Patient Heterogeneity in Dose-Finding Trials, Part 2: Methods for K groups, Henry Stewart Talks, Virtual, August 2017
Horton BJ, Continual Reassessment Method for Partially Ordered Groups, Joint Statistical Meetings, Baltimore MD, August 2017
Wages NA, Model-based design for the early development of combination immunotherapies, Joint Statistical Meetings, Baltimore MD, August 2017
Horton BJ, Continual Reassessment Method for Partially Ordered Groups, Symposium on Early Phase Dose Finding Methodology, University of Virginia, Charlottesville VA, April 2017
Petroni GR, Implementation of Adaptive Methods in Early Phase Clinical Trials, Henry Stewart Talks, Virtual, March 2017
Wages NA, A web application for conducting the continual reassessment method, Statistical Practice in Cancer Conference Moffitt Cancer Center, Tampa FL, March 2017
Conaway MR, Designs for contemporary dose-finding trials, Children’s National Medical Center, Washington DC, September 2016
Wages NA, Phase I design for locating schedule-specific maximum tolerated doses, International Chinese Statistical Association Symposium, Atlanta GA, June 2016
Conaway MR, Using Hwang-Peddada Estimates in Combination Agent Trials and in Trials with Heterogeneous Groups, Symposium on Early Phase Dose Finding Methodology, University of Paris, Paris France, April 2015
Horton BJ, Comprehensive evaluation of CRM, mTPI, and 3+3 relative to a benchmark, Symposium on Early Phase Dose Finding Methodology, University of Paris, Paris France, April 2015
Petroni GR, Issues to Consider in the Design and Implementation of Early Phase Adaptive Clinical Trials, Symposium on Early Phase Dose Finding Methodology, University of Paris, Paris France, April 2015
Wages NA, Identifying multiple MTD combinations in two-dimensional dose-finding, Symposium on Early Phase Dose Finding Methodology, University of Paris, Paris France, April 2015
Conaway MR, Using Hwang-Peddada Estimates in Combination Agent Trials and in Trials with Heterogeneous Groups, Medical University of South Carolina, Charleston SC, October 2014
Wages NA, Continual reassessment method for phase I oncology trials of combined drugs, Society for Clinical Trials meeting, Philadelphia PA, May 2014
Wages NA, Early-phase dose-finding design for molecularly targeted agents, 3rd Workshop on Adaptive Early-phase Clinical Trial Designs, Ann Arbor MI, September 2013
Conaway MR, Designs for partially-ordered phase I trials: combinations of agents and groups of patients, American Society for Clinical Oncology Pre-Meeting Workshop, Chicago IL, June 2013
Wages NA, Phase I design for multiple treatment schedules: the problem of partial ordering in dose-finding, Society for Clinical Trials meeting, Boston MA, May 2013
Conaway MR, Designs for Partially Ordered Phase I Trials, American Statistical Association Annual Meetings, San Diego CA, July 2012
Conaway MR, Contemporary Designs in Early-Phase Clinical Trials, American Society for Clinical Oncology Pre-Meeting Workshop, Chicago IL, June 2012
Wages NA, The problem of partial ordering in Phase I clinical trials, SRCOS Summer Research Conference, Jekyll Island GA, June 2012
Conaway MR, Designs for phase I trials of combinations of agents, ENAR, Washington DC, April 2012
Conaway MR, Ordered restricted inference and model-based designs for partial orders, Continual Reassessment Method and Related Issues in Dose-finding Workshop, Paris France, September 2011
Wages NA, Dose-finding for multi-drug combinations, Continual Reassessment Method and Related Issues in Dose-finding Workshop, Paris France, September 2011
Conaway MR, Phase I Trials for Combinations of Agents, Georgetown University, Washington DC, February 2011
Conaway MR, Phase I Trials for Combinations of Agents, Penn State Cancer Institute, Hershey PA, November 2010
Conaway MR, Phase I Trials for Combinations of Agents, University of West Virginia, Morganton WV, November 2010
Conaway MR, Phase I Trials for Combinations of Agents, University of Colorado, Denver CO, September 2010
Conaway MR, Phase I Trials for Combinations of Agents, University of Connecticut, Storrs CT, June 2010
Conaway MR, Designs for Phase II trials with response and toxicity endpoints, Society for Clinical Trials Annual Meeting, New Orleans LA, May 2004
Conaway MR, Designs for partially ordered phase I trials, University of Pittsburgh, Pittsburgh PA, March 2003
Conaway MR, Designs for partially ordered phase I trials, University of Virginia Cancer Center, Charlottesville VA, December 2002